1-2 of 2
David Siegel
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Final analysis of carfilzomib, dexamethasone, and daratumumab vs carfilzomib and dexamethasone in the CANDOR study

Clinical Trials & Observations
Saad Z. Usmani, Hang Quach, Maria-Victoria Mateos, Ola Landgren, Xavier Leleu, David Siegel, Katja Weisel, Xiaomei Shu, Chuang Li, Meletios Dimopoulos
Journal: Blood Advances
Blood Adv (2023) 7 (14): 3739–3748.
https://doi.org/10.1182/bloodadvances.2023010026
Published: 2023
Includes: Supplemental data
Journal Articles

Efficacy and safety of carfilzomib-based regimens in frail patients with relapsed and/or refractory multiple myeloma

Clinical Trials & Observations
Thierry Facon, Ruben Niesvizky, Maria-Victoria Mateos, David Siegel, Cara Rosenbaum, Sara Bringhen, Katja Weisel, P. Joy Ho, Heinz Ludwig, Shaji Kumar, Kenneth Wang, Mihaela Obreja, Zhao Yang, Zandra Klippel, Khalid Mezzi, Amanda Goldrick, Christina Tekle, Meletios A. Dimopoulos
Journal: Blood Advances
Blood Adv (2020) 4 (21): 5449–5459.
https://doi.org/10.1182/bloodadvances.2020001965
Published: 2020
Includes: Supplemental data